A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2006
10/18/2006	CN1849130A Use of gentiana lutea extracts as an antimicrobial agent
10/18/2006	CN1847392A Process of producing gene engineering subunit vaccine of chicken's infectious bursal disease with colibacillus
10/18/2006	CN1847263A Protein from snake venom for preventing and treating pyemia
10/18/2006	CN1847262A One kind of protein and its use
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847256A Antiviral prepn containing both CpG single-strand deoxyoligonucleotide and ribavirin
10/18/2006	CN1847252A Prepn process and medicinal composition of amorphous Adefovir dipivoxil
10/18/2006	CN1847243A Prepn process and prepn of new soluble voriconazole salt
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1846786A Vaccins vivants recombines et adjuves
10/18/2006	CN1846776A Injection of long-chain fat from zedoary oil and its prepn process
10/18/2006	CN1846748A Cold-treating Fupu effervescent tablet and its prepn process and quality control method
10/18/2006	CN1846732A Veterinary medicine for animal's epimedic disease and its prepn process and application
10/18/2006	CN1846730A Chaihuang soft capsule preparing process and its quality control technology
10/18/2006	CN1846726A Capillary artemisia dripping pill and its prepn process
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846717A Medicine for treating influenza and bird flu
10/18/2006	CN1846702A Dispersed cefditoren pivoxil tablet and its prepn process
10/18/2006	CN1280410C Cholera vibrio strain
10/18/2006	CN1280310C Fusion protein with cold proventing and curing function and its encoding gene and use
10/18/2006	CN1280304C Fern effective part and compound fern glycoside and its separaton and purification method
10/18/2006	CN1280303C Artificial composite deoxygenation oligonucleotide with CpG single chain being contained, and effect of anti SARS virus
10/18/2006	CN1280302C Novel macrolide derivative having effect of potentiating anti-fungus activity
10/18/2006	CN1280293C Improved method for making nevirapine
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280279C Dibenzo-isozaolone compounds and their synthesis process and application
10/18/2006	CN1280266C Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
10/18/2006	CN1279979C Nucleic vaccine for tubercle bacillus
10/18/2006	CN1279978C Purification method of dermatonecrotoxin and anatoxin produced by Bordetella
10/18/2006	CN1279974C Technology for preparing capsule of liver cell growth promoting factor
10/18/2006	CN1279966C Danduqing granular and its preparation method
10/18/2006	CN1279940C Antiseptic and pest killing skin cleaning agent and preparing method
10/18/2006	CN1279937C Antiseptic and insect killing washing liquid and preparing method
10/18/2006	CN1279920C Slow release preparation of diammonium glycyrrhizate
10/18/2006	CN1279913C Compound preparation containing rifampicin and isoniazid and its preparing method
10/18/2006	CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/18/2006	CN1279901C Pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
10/18/2006	CN1279890C Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases
10/17/2006	US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122638 Hybridomas cell lines; viricides
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122618 Cosmetics, drugs, plant safening agents, microbiocides, textiles
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	US7122528 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
10/17/2006	US7122525 Targeted therapeutics and uses thereof
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
10/17/2006	US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
10/17/2006	US7122347 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122302 Method for determining early HCV seroconversion
10/17/2006	US7122197 Compounds from Moraxella catarrhalis
10/17/2006	US7122196 Compounds and methods for diagnosis of tuberculosis
10/17/2006	US7122194 Mixture of polypeptide with carrier
10/17/2006	US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006	CA2359659C Method for quality control of an attenuated varicella live vaccine
10/17/2006	CA2324919C Hiv inhibiting pyrimidine derivatives
10/17/2006	CA2197207C Hiv protease inhibitor combination
10/12/2006	WO2006107851A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
10/12/2006	WO2006107097A1 Nasal vaccine
10/12/2006	WO2006107059A1 Medicine for renal perfusion disorder
10/12/2006	WO2006106711A1 Antifungal agent containing pyridine derivative
10/12/2006	WO2006106427A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
10/12/2006	WO2006106426A1 An oxindole oxazolidinone as antibacterial agent
10/12/2006	WO2006106169A1 Phosphorothioates derived from nucleoside analogues for antiretroviral therapy
10/12/2006	WO2006106103A2 Prevention of hiv- infection with tmc278
10/12/2006	WO2006105811A1 Compounds useful as modulators of the proteasome activity
10/12/2006	WO2006105728A1 Diarylheptanoids, preparation and the use thereof
10/12/2006	WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response
10/12/2006	WO2006088664A3 Flavivirus ns5a proteins for the treatment of hiv
10/12/2006	WO2006061217A3 Saquinavir derivatives useful in immunoassay
10/12/2006	WO2006048336A3 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents
10/12/2006	WO2005123774A3 Antibodies to west nile virus polypeptides
10/12/2006	US20060230467 Plant deoxyribonucleoside kinase enzymes and their use
10/12/2006	US20060229436 activation of alpha-lactalbumin comprising contacting (in molten globule-like state) with fatty acids and lipids found in milk fractions containing casein obtained from humans; antibacterial agents; anticancer agents
10/12/2006	US20060229356 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions
10/12/2006	US20060229336 HIV, acquired immune deficiency syndrome (AIDS); 1-(8-{2-[1-(2,2-Dimethylpropanoyl)-4-phenylpiperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1H-benzimidazole
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229322 Anhydrous crystalline form of valacyclovir hydrochloride
10/12/2006	US20060229316 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229295 Amide derivatives
10/12/2006	US20060229234 Peptide factor
10/12/2006	US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders
10/12/2006	US20060228417 Mucoadhesive composition comprising polyacrylate and chemoattractant
10/12/2006	US20060228407 Enhanced delivery via serpin enzyme complex receptor
10/12/2006	US20060228373 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant
10/12/2006	US20060228342 Method for generating antigen-presenting cells
10/12/2006	US20060228341 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/12/2006	CA2604488A1 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
10/12/2006	CA2604133A1 Compounds useful as modulators of the proteasome activity
10/12/2006	CA2603943A1 An oxindole oxazolidinone as antibacterial agent
10/12/2006	CA2603899A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents

1 ... 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 ... 1798